HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Brain Stimulation System Treats Tremor Patients

By HospiMedica International staff writers
Posted on 29 Oct 2014
Print article
Boston Scientific\'s Vercise DBS IPG, leads, and remote control
The Vercise DBS IPG, leads, and remote control (Photo courtesy of Boston Scientfic )
Innovative deep-brain stimulation (DBS) system provides precise neural targeting to customize therapy for patients with tremor.

The Vercise DBS system is intended for patients with Parkinson’s disease (PD), primary and secondary dystonia, and essential tremor (ET). The system impulse generator (IPG) possesses a gentle, contoured oval shape with a small footprint of just 20 cm2. The IPG is accompanied by a multilumen lead that includes 8 contacts and a broad span. Targeting is achieved using a multiple independent current control (MICC) platform, which allows selective control of the electric current delivered through each individual electrode.

Unique rechargeable battery technology proffers the system with a 25 year life span, helping to reduce surgical interventions; and zero Volt battery technology ensures that even if the battery is completely discharged, there will be no failure or damage. The charging system, as is the remote control, are completely cordless, allowing patients to remain active. The Vercise DBS system is a product of Boston Scientific (Natick, MA, USA), and has received the European Community CE marking of approval.

“With the launch of the Vercise DBS System for the treatment of patients with Parkinson's disease in 2012, for dystonia in 2013, and now for tremor, Boston Scientific continues to demonstrate its commitment to provide more access to DBS therapy to more patients,” said Maulik Nanavaty, president of neuromodulation at Boston Scientific. “We believe this advanced technology can play a critical role in improving the lives of patients who suffer from these devastating conditions.”

“Essential tremor can be very debilitating for patients in their day-to-day activities such as writing and eating,” said Prof. Veerle Visser Vandewalle, MD, of University Hospital Cologne (Germany), who implanted the first European system. “The Vercise DBS System provides advanced tremor care through precise neural targeting that is designed to manage ET symptoms effectively and improve patient quality of life.”

ET is a neurological disorder that causes a rhythmic shaking, and can affect almost any part of the body, but occurs most often in the hands, especially when intent is present, such as drinking from a glass, holding a fork, writing, or shaving. Although not a dangerous condition, ET worsens over time. It can occur at any age, but is most common in people age 40 and older.

Related Links:

Boston Scientific


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Remote Controlled Digital Radiography and Fluoroscopy System
Eco Track-DRF - MARS 50/MARS50+/MARS 65/MARS 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more